Ipamorelin vs GHRP-2

At-a-Glance Comparison

Ipamorelin: Selective GH Secretion

Ipamorelin is a synthetic pentapeptide (Aib-His-D-2Nal-D-Phe-Lys-NH2) that acts as a growth hormone releasing peptide (GHRP) with extraordinary selectivity. Unlike older GHS molecules, Ipamorelin stimulates GH release without meaningfully affecting prolactin or cortisol—a major advantage in long-term therapy.

The mechanism: Ipamorelin binds to ghrelin-like receptors in the pituitary, triggering GH secretion. Each injection produces a modest, physiological GH pulse (2–4 IU), mimicking the body's natural pulsatile pattern. Critically, Ipamorelin does not suppress somatostatin, allowing for clean, brief GH spikes without extended suppression of other hormones.

This selectivity makes Ipamorelin ideal for sustained use—months or years—without hormone imbalance. Users report improved body composition, enhanced recovery, and anti-aging benefits with minimal side effects.

GHRP-2: High-Impact GH Stimulus

GHRP-2 (pralmorelin, hexarelin class) is a potent GH secretagogue that delivers larger, faster GH pulses than Ipamorelin—up to 15 IU per injection. It binds ghrelin receptors and strongly stimulates GH-releasing hormone (GHRH) pathways in the hypothalamus and pituitary.

The mechanism is more aggressive: GHRP-2 increases not only GH but also prolactin and cortisol (acutely). This multi-hormone effect accelerates muscle protein synthesis but carries trade-offs—water retention from prolactin, appetite stimulation from ghrelin-like action, and theoretical risk of prolactin-related side effects over time.

GHRP-2 is the choice for rapid mass gain, power athletes, and shorter cycles (8–12 weeks) where the higher hormonal impact justifies the side effects. Users often stack GHRP-2 with GHRH peptides (like Sermorelin) to amplify and modulate the GH response for even greater gains.

Hormonal Profile & Muscle Growth Effects

Growth Hormone (GH) & IGF-1: Both peptides boost GH, which stimulates IGF-1 production (liver, skeletal muscle). Ipamorelin's modest pulses create sustained, stable IGF-1 elevation. GHRP-2's larger spikes may yield faster IGF-1 surges, driving quicker muscle protein synthesis.

Prolactin: Ipamorelin does not elevate prolactin. GHRP-2 raises prolactin moderately, causing water retention, potential gynecomastia risk, and erectile dysfunction in sensitive users. Prolactin management with a dopamine agonist (like Caber) is sometimes needed on GHRP-2 cycles.

Appetite & Ghrelin: GHRP-2 powerfully stimulates hunger (ghrelin-like), which aids bulking but can be problematic for body composition-focused goals. Ipamorelin has minimal appetite effect, allowing diet control.

Cortisol: GHRP-2 can acutely suppress cortisol, beneficial short-term but potentially problematic chronically. Ipamorelin maintains cortisol homeostasis. For lean, durable gains and joint/tissue health, Ipamorelin is superior. For maximum muscle gain speed, GHRP-2 edges ahead. See Ipamorelin and GHRP-2 detailed guides for more.

Applications: Bodybuilding, Anti-Aging, Recovery

Ipamorelin Use Cases: Anti-aging and longevity (sustained, low-side-effect GH elevation); lean body recomposition; joint and connective tissue healing; enhanced recovery from training without bulk; long-term therapy (12+ months). Ideal for older adults, endurance athletes, and those avoiding water retention.

GHRP-2 Use Cases: Rapid muscle mass gain; strength athlete performance; cutting cycles (body recomposition with aggressive training); shorter, higher-intensity protocols (8–16 weeks). Best for young, healthy males optimizing muscle hypertrophy with tolerance for hormonal manipulation.

Stacking Strategy: Many advanced users combine both. GHRP-2 (morning/noon/pre-bed) with Ipamorelin (additional daytime injection) amplifies GH output while offsetting GHRP-2 side effects. GHRP-2 + GHRH peptides (Sermorelin, Tesamorelin) is another popular stack, with the GHRH peptide modulating the GHRP-2 stimulus.

Recovery is enhanced by both—increased GH accelerates muscle repair, bone healing, and CNS recovery. For injury rehabilitation, Ipamorelin's sustained selectivity offers advantages. For athletic competition requiring rapid strength gains, GHRP-2 is often the choice.

Dosage & Administration Protocols

Ipamorelin Dosage: Standard is 100–200 mcg per subcutaneous injection, 2–3 times daily. Total daily dose: 300–600 mcg. Some users dose once daily (200 mcg) if convenience is prioritized. Cycles: continuous (12+ months) or 3 months on, 1 month off. Best injected away from meals (fasted or 2+ hours post-meal).

GHRP-2 Dosage: Typically 100–200 mcg per injection, 3 times daily (morning, noon, pre-bed). Total daily dose: 300–600 mcg. Higher frequencies (4x daily) are sometimes used for maximum GH output. Cycles: 8–16 weeks on, 4 weeks off (to allow pituitary recovery and prevent tolerance).

Optimal Timing: Ipamorelin: morning (fasted), afternoon (pre-workout), evening (before sleep). GHRP-2: same timing, but many prefer pre-bed dose to leverage sleep-induced GH surge. Always inject subcutaneously into clean skin (abdomen, thigh, or rotate).

Stack Dosing: If combining: GHRP-2 100 mcg (3x) + Ipamorelin 100 mcg (additional 1–2x) daily, total 500–700 mcg/day. This approach reduces GHRP-2 prolactin/cortisol impact while maximizing GH. Start conservative, increase based on blood work (IGF-1, prolactin).

Side Effects & Safety

Ipamorelin Side Effects: Minimal and rare. Mild injection site reactions, occasional flushing or dizziness. No significant prolactin, cortisol, or appetite effects. Long-term human data is limited, but animal studies and clinical use suggest excellent safety at therapeutic doses. Tolerance is uncommon.

GHRP-2 Side Effects: Increased hunger (ghrelin-like), water retention (from prolactin), flushed skin or facial flushing, mild dizziness. More serious risks with extended use: prolactin elevation (gynecomastia, erectile dysfunction, lactation), carpal tunnel syndrome (from GH), and desensitization (tolerance requiring higher doses or cycling off).

Blood Work Monitoring: Test baseline IGF-1, prolactin, cortisol, glucose, and lipids. Recheck IGF-1 and prolactin every 8 weeks on GHRP-2 cycles. For Ipamorelin, quarterly monitoring is sufficient. Prolactin >30 ng/mL on GHRP-2 warrants dopamine agonist use (Cabergoline 0.25–0.5 mg 2x weekly).

Contraindications: Active cancer, uncontrolled diabetes, pregnancy/nursing. GHS may accelerate existing tumors. Carpal tunnel syndrome, severe arthritis, or joint instability may worsen with GH elevation. Always consult a doctor before use. See peptide safety guidelines for comprehensive harm reduction.

Which Peptide Is Right for You?

Choose Ipamorelin if: You prioritize long-term health and minimal side effects. You are 40+ years old or interested in anti-aging. You want lean gains and body recomposition. You prefer one injection daily or can commit to 2–3 without burden. You are sensitive to prolactin-related side effects. You plan cycles >12 weeks.

Choose GHRP-2 if: You want maximum muscle gain speed in a 8–16 week window. You are willing to manage higher prolactin and water retention. You are young (<35) and training aggressively. You can commit to 3x daily injections. You have access to blood work monitoring and dopamine agonist if needed. You are willing to cycle off periodically.

Stack Both if: You want to optimize both GH stimulus and selectivity. You have advanced experience and good injection discipline. You can monitor prolactin/IGF-1 closely. This combines Ipamorelin's safety with GHRP-2's potency for balanced, sustainable gains.

The "best" peptide depends on your age, goals, timeline, and willingness to manage hormonal side effects. Younger athletes pushing for size may prefer GHRP-2; older individuals seeking anti-aging should choose Ipamorelin. Both are effective; the choice reflects priorities.